These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3959033)

  • 41. 10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis.
    Covey DF; Hood WF; Parikh VD
    J Biol Chem; 1981 Feb; 256(3):1076-9. PubMed ID: 7451489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis of 19-oxygenated derivatives of the competitive inhibitor of aromatase, 5-androstene-4,17-dione.
    Numazawa M; Yamada K
    Steroids; 1999 May; 64(5):320-7. PubMed ID: 10406481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical and pharmacological development of steroidal inhibitors of aromatase.
    Brueggemeier RW; Li PK; Chen HH; Moh PP; Katlic NE
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):379-85. PubMed ID: 2257241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tritium release from [19-3H]-19,19-difluoroandrost-4-ene-3,17-dione during inactivation of aromatase.
    Furth PS; Robinson CH
    Biochemistry; 1989 Feb; 28(3):1254-9. PubMed ID: 2653438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition and inactivation of estrogen synthetase (aromatase) by fluorinated substrate analogues.
    Marcotte PA; Robinson CH
    Biochemistry; 1982 May; 21(11):2773-8. PubMed ID: 7093221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line.
    Block JL; Block NL; Lokeshwar BL
    Cancer Lett; 1996 Mar; 101(2):143-8. PubMed ID: 8620462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
    Lesuisse D; Gourvest JF; Hartmann C; Tric B; Benslimane O; Philibert D; Vevert JP
    J Med Chem; 1992 May; 35(9):1588-97. PubMed ID: 1578485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis.
    Darby MV; Lovett JA; Brueggemeier RW; Groziak MP; Counsell RE
    J Med Chem; 1985 Jun; 28(6):803-7. PubMed ID: 4009603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships.
    Numazawa M; Oshibe M
    J Med Chem; 1994 Apr; 37(9):1312-9. PubMed ID: 8176709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.
    Su B; Hackett JC; Díaz-Cruz ES; Kim YW; Brueggemeier RW
    Bioorg Med Chem; 2005 Dec; 13(23):6571-7. PubMed ID: 16125392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the effect of 4-hydroxy-4-androstene-3,17-dione on aromatase activity in granulosa cells from preovulatory follicles of rats, rabbits, and humans.
    Koos RD; LeMaire WJ; Hung TT; Brodie AM
    Steroids; 1985 Feb; 45(2):143-50. PubMed ID: 4089916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ; Porubek DJ; Nelson SD
    J Med Chem; 1985 Jun; 28(6):775-9. PubMed ID: 4009599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione.
    Daly MJ; Jones GW; Nicholls PJ; Smith HJ; Rowlands MG; Bunnett MA
    J Med Chem; 1986 Apr; 29(4):520-3. PubMed ID: 3754286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent enzyme-activated inhibition of aromatase by a 7 alpha-substituted C19 steroid.
    Snider CE; Brueggemeier RW
    J Biol Chem; 1987 Jun; 262(18):8685-9. PubMed ID: 3597393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
    Covey DF; Hood WF
    Mol Pharmacol; 1982 Jan; 21(1):173-80. PubMed ID: 7132956
    [No Abstract]   [Full Text] [Related]  

  • 59. 1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase.
    Vinh TK; Ahmadi M; Delgado PO; Perez SF; Walters HM; Smith HJ; Nicholls PJ; Simons C
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2105-8. PubMed ID: 10450990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analogues of 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione as selective inhibitors of aromatase: derivatives with variable 1-alkyl and 3-alkyl substituents.
    Leung CS; Rowlands MG; Jarman M; Foster AB; Griggs LJ; Wilman DE
    J Med Chem; 1987 Sep; 30(9):1550-4. PubMed ID: 3625703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.